Optimi Health is trading 5.88% up at $5.04, but no clear company-specific announcement dated September 15, 2026, explains the move.

  • The stock is extending its second consecutive advancing session.
  • Recent coverage centers on the September 10 Health Canada-authorized Phase 2 trial announcement and the September 14–16 H.C. Wainwright conference; neither is explicitly linked to today’s trading.
  • Broader markets and biotech are declining, so the catalyst remains unclear.